The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours—Single-Centre Experience and Literature Review
<i>Background and Objectives</i>: The opsoclonus-myoclonus syndrome (OMS) is characterised by opsoclons, myoclons and impaired balance, often concomitant with sleep disorder and behavioural difficulties. The symptoms develop as a result of autoimmune response triggered by a neuroblastic...
Main Authors: | Agnieszka Mizia-Malarz, Weronika Stolpa, Grażyna Sobol-Milejska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/56/8/412 |
Similar Items
-
Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge
by: Marina Auconi, et al.
Published: (2021-10-01) -
Hyperammonemia presenting as opsoclonus–myoclonus–ataxia–tremor syndrome: A case report
by: Sandhya Manorenj, et al.
Published: (2022-01-01) -
Opsoclonus-myoclonus-ataxia syndrome presenting in Enugu, Southeast Nigeria: A case report
by: Adaobi Ikemeh, et al.
Published: (2019-01-01) -
Evolving Cognitive Dysfunction in Children with Neurologically Stable Opsoclonus–Myoclonus Syndrome
by: En Lin Goh, et al.
Published: (2020-08-01) -
Recommendations for Neuroblastoma Associated Opsoclonus-myoclonus-ataxia Syndrome in Childhood
by: Chinese Research Hospital Association- Children's Oncology Committee, et al.
Published: (2022-07-01)